Objective: Stimulation of A3 adenosine receptors has been shown to protect cardiac myocytes from ischemic injury, but the mechanism of this action is unknown. We evaluated the effect of adenosine agonists and antagonists on the sarcoplasmic reticulum (SR) 21 Ca channels. Methods: Isolated rat hearts were perfused with control buffer or different adenosine agonists and antagonists. Hearts 21 21 were then homogenized and used to determine SR Ca -induced Ca release, assayed by quick filtration technique after loading with 
Introduction
with the A3 receptor [5, 6] and that ischemic injury can be reduced by A3 agonists, suggesting a role of A3 receptor Adenosine is known to exert a cardioprotective effect in stimulation in the protective action of adenosine [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] . myocardial ischemia and reperfusion [1, 2] , and it has been
The effector mechanisms responsible for the beneficial proposed as mediator of ischemic preconditioning [3, 4] . action of adenosine are poorly understood. Hemodynamic The transduction pathways involved in the response to changes, metabolic effects, or activation of ATP-dependent 1 adenosine have not been definitely established. The protec-K channels have been proposed as mediators of A1 tive effect has been initially attributed to stimulation of A1 responses. In the case of A3 stimulation, the matter is even receptors, since it was reproduced by A1 agonists such as more obscure. Although A3 receptors are expressed in 6 6 N -cyclopentyladenosine or N -R-phenylisopropyladenocardiac myocytes [5, 14] , their functional role is unknown. sine. However, in several experimental models protection On the basis of pharmacological studies, either protein was not abolished by selective A1 antagonists. Further kinase C [11] or K channels [18, 19] reperfusion [20] , and this phenomenon is likely to be subjected to 30 min of global ischemia, obtained by the involved in the pathogenesis of ischemic preconditioning occlusion of the aortic and atrial cannulas, and 120 min of [21] . In the present work we used an isolated rat heart retrograde reperfusion (aortic pressure 70 mmHg). Tissue model to characterize the cardioprotective action of adenoinjury was then measured on the basis of triphenyltetsine agonists, and to investigate their effects on the SR razolium chloride (TTC) staining, as described previously 21 Ca release channel / ryanodine receptor. [21] . In a few experiments, the duration of ischemia was prolonged to 45 min. During the ischemic period, the heart chamber was filled with perfusion buffer, whose tempera-2. Methods ture was monitored and kept at 36.860.18C. Standard buffer (without any addition) was always used in the final 2.1. Animals and perfusion technique 120-min of retrograde reperfusion, and it was not recirculated. Male Wistar rats (275-300 g body weight), fed with standard diet, were anesthetized with a mixture of ether 2.2. Preparation of cellular fractions and air. After injection of 1000 U sodium heparin in the femoral vein, the heart was quickly excised and perfused At the end of the perfusions aimed at determining 21 21 3
according to the working heart technique, as described Ca -induced Ca release or [ H]ryanodine binding, previously [20] . Experimental procedures were approved ventricles were homogenized as described previously [20] . by the ethical committee of the University of Pisa. The
In some experiments, assays were performed in the crude investigation conforms with the Guide for the Care and homogenate. In others, the homogenate was used to Use of Laboratory Animals published by the US National prepare a microsomal fraction enriched in SR, as described Institutes of Health (NIH Publication No.85-23, revised previously [20] . 1996). Adenosine agonists or antagonists were added to the 2.3. Assay of [ H] ryanodine binding and of SR Ca perfusion buffer after 5 min of control perfusion, and release hearts were treated with these substances for an additional 6 15-min period. The following substances were used: N -RHigh affinity ryanodine binding was assayed as dephenylisopropyladenosine (R-PIA), an A1 agonist that is scribed previously [20] . Unless otherwise specified, free 21 over 100-fold selective for A1 vs. A2 receptors, whose Ca concentration was 18 mmol / l. The difference be-A1 /A3 affinity ratio has been reported to be in the range of tween the counts of duplicate samples was ,10% in all 50:1 (cloned rabbit receptor) [22] 22, 25] ; MRS 1191 (3-ethyl-5-benzyl-2-methyl-4-phenylethynyl-6-phenyl-1,4-(6)-dihydropyridine-3,5-dicarb-2.4. Chemical and radionuclides oxylate), an A3 antagonist that is over 1,000-and 3,000-fold selective for A3 vs. A1 and A2a receptors, respective-R-PIA, CPX, CGS 21680, dantrolene and EGTA were ly [25] susceptibility to ischemia. The protective effect of R-PIA were evaluated as follows. One-way analysis of variance was preserved in the presence of 100 nmol / l CPX or 20 was used as a global test for differences between means. If nmol / l ZM 241385, whereas it was abolished by the A3 between-groups variance was significantly (P,0.05) highantagonist MRS 1191, at 1 mmol / l concentration ( Fig. 2 , er than within-groups variance, appropriate post-hoc tests upper panel). Analysis of contractile performance conwere performed. In experiments aimed at determining firmed dissociation between cardioprotection and A1 redifferences versus a single control group, Dunnett's test sponse. Perfusion with R-PIA determined dose dependent was applied; in experiments projected for pairwise comreductions of heart rate, aortic flow and cardiac output, parisons of all groups, Student-Neuman-Keul's test was consistent with the well-known effects of A1 receptor applied. GraphPad Prism version 3.02 for Windows (Graphstimulation. If R-PIA was used in the presence of 100 Pad Sofware, San Diego, CA) was used for data processing nmol / l CPX, negative chronotropic and inotropic actions and statistical analysis.
were abolished, confirming that CPX caused effective A1 blockade. On the other hand, MRS 1191 did not modify the hemodynamic effects of R-PIA, showing no evidence 3. Results of A1 antagonism. Perfusion by IB-MECA produced moderate increase in 3.1. Myocardial protection coronary flow, while no A1 effect (particularly, no change in heart rate) was produced. Changes in coronary flow When control hearts were challenged by 30 min of were blocked by ZM 241385 but they were not affected by sustained ischemia and 120 min of reperfusion, the extent MRS 1191, suggesting an A2 action. However, the protecof myocardial necrosis, as evaluated by TTC staining, tive effect of IB-MECA was abolished by MRS 1191, corresponded to 31.662.4% of the ventricular mass. We while it was not affected by the A2 antagonist ZM 241385 first determined the effect of adenosine agonists on is- (Fig. 2 , lower panel). On the whole, our results suggest The pharmacological profile of ryanodine receptor R-PIA or 100 nmol / l IB-MECA, K decreased by about r modulation, as evaluated by using different adenosine 25-30% (P,0.05). receptor antagonists, was similar to the pharmacological profile of cardioprotection. In particular, the effect of R-PIA was abolished by MRS 1191, while it was not 3.4. Microsomal fraction experiments affected by either CPX or ZM 241385 (Fig. 4, upper  panel) . The effect of IB-MECA was also abolished by
The experiments described in the previous sections were MRS 1191 (Fig. 4, lower is associated with modifications of the SR Ca channel dial ischemia or ischemia-reperfusion has been extensive-(ryanodine receptor), which might delay the development ly investigated. The rat had been initially considered as an 21 of cytosolic Ca overload [21] . For these reasons, we adenosine-insensitive species, since adenosine infusion did investigated the effect of adenosine agonists on the not reduce ischemic injury either in vivo or in isolated ryanodine receptor. Ryanodine binding was reduced, and perfused hearts [27, 28] . However, the rate of adenosine the pharmacological profile of this action was consistent catabolism is particularly high in this species, and negative with an A3 effect. As observed after ischemic precondiresults might be accounted for by extensive breakdown of tioning [21] , ryanodine receptor changes consisted in exogenous adenosine in blood cells, endothelium, or moderate decrease of binding site density, whereas the cardiomyocytes. The present findings support this interpre-21 affinity for ryanodine and the Ca -dependence of tation, since remarkable protection was elicited by nonryanodine binding were unaffected. metabolizable adenosine derivatives, which is consistent 6 Ryanodine binding is often used as a tool to evaluate the with the reported effectiveness of 2-chloro-Nfunctional state of the SR channel, since increased binding cyclopentyladenosine [29] .
is usually associated with increased open probability of the The signaling pathway involved in the protective effect channel and vice-versa [32, 33] . There are, however, some of adenosine derivatives has not been fully characterized.
exceptions to this rule [33] . Therefore, we assayed SR In particular, the relative role of A1 and A3 receptors is 21 21
Ca -induced Ca release, confirming that it was decontroversial, and species differences might be important creased by IB-MECA and R-PIA. [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] . Our findings suggest that, in rat heart, cardiac Most of our experiments were performed in crude protection is mainly due to A3 receptor stimulation. In homogenate, because purification procedures may select fact, the protective action of R-PIA was not modified by vesicles that are not representative of the whole SR CPX, although the latter abolished the functional conse-21 [20, 34] . SR Ca release can be reliably measured in crude quences of A1 stimulation (e.g. heart rate reduction), while 21 preparations, since no other structure can support Ca it was prevented by A3 antagonist MRS 1191. Inrelease that has t on the order of a few milliseconds and volvement of A3 receptors was confirmed by the effective-
is inhibited by Mg and ruthenium red. In any case, we ness of A3 agonist IB-MECA, whose protective effect was repeated the assay in a microsomal preparation, with also abolished by MRS 1191. IB-MECA did not produce similar results. any negative chronotropic or inotropic action, while it
The functional implications of ryanodine receptor moducaused slight increase in coronary flow, which was prelation by adenosine are not easy to predict. In our vented by A2 antagonist ZM 241385. A2-mediated corexperiments, contractile performance was not affected by onary dilation by IB-MECA has also been reported in rat IB-MECA, and similar results (i.e. unchanged contractility by Lasley et al. [30] , and it is probably related to the large with reduced ryanodine binding) were obtained after brief A2a receptor reserve for coronary vasodilation [31] . The ischemia and reperfusion [21] . It seems that, under basal increase in coronary flow observed in the presence of 21 conditions, moderate reduction of SR Ca release capa-R-PIA and CPX also might represent an A2 effect, bility does not affect contractile protein activation. Howunmasked by inhibition of the A1 response. However, ZM 21 ever, under conditions of increased Ca cycling, even 241385 did not affect the protective effect of IB-MECA or slight changes in SR channel function might become R-PIA, suggesting that A2 stimulation played no role in it.
critical. In particular, inotropic stimulation -produced by IB-MECA was effective at concentrations that are either physiological stimuli (e.g. adrenergic effectors) or higher than its K , as assessed in vitro, in cells transfected d pharmacological agents (e.g. digoxin) -is usually associwith cloned rabbit A3 receptor (about 2 nmol / l) [22] . 21 ated with increased SR Ca content and increased SR However, species differences in the affinity of adenosine 21 Ca release. Cardiac A3 receptors might modulate the receptor agonists have been described, and the pharmaresponse to inotropic stimuli, which is consistent with the cology of rat A3 receptor has not been characterized. In concept that adenosine is a 'retaliatory metabolite', origiaddition, the relationship between intracoronary and internally introduced with regard to A1 and A2 effects only stitial concentration of adenosine is not known, although 21 [35] . Modulation of SR Ca release should also determine this is obviously a crucial issue for interpretation of intact important consequences during sustained ischemia, since heart experiments. Protection by IB-MECA has been theoretical considerations and experimental findings [36] observed, at 10-100 nmol / l concentration, in rabbit heart 21 and in chicken cardiomyocytes [12, 13, 15] , which is consuggest that ischemia is associated with increased SR Ca 21 sistent with our findings. cycling, and that SR Ca release plays a major role in the 21 The cellular mechanism of the protective effect of development of cytosolic Ca overload, which is one of adenosine is poorly characterized, and the effectiveness of the chief determinants of irreversible cellular injury. A3 agonists is puzzling, since the physiological role of It is difficult to prove the existence of a causal relation-ship between ryanodine receptor modulation and cardiac References protection. We have compared the response to IB-MECA and to dantrolene, a ryanodine receptor antagonist which [ mental [41] in rat heart models of ischemia-reperfusion.
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In other experimental models, the cardioprotective ac- inhibitor of K channels [18, 19] , suggesting that A3 receptors to SR Ca channels remains to be determined. reported to activate phospholipases C and D [25] . In some 
